Skip to main content

MoneyWorks4Me

Jeevan Scientific Technology informs about company updates

21 Dec 2016 Evaluate

Jeevan Scientific Technology has informed that the Company’s Clinical Pharmacology Centre to conduct Bioavailability/Bioequivalence studies has been approved by the ‘Office of Drug Control General, India (DCGI)’ on 16-December-2016 for a period of Three years. This Centre having four independent clinics having a total capacity of 132 beds will facilitate end-to-end Bioequivalence studies by Jeevan Scientific Technology.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
TCS 2428.50
Infosys 1147.90
HCL Technologies 1378.00
Wipro 195.95
Tech Mahindra 1769.30
View more..